pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-758 |
Genomic Coordinates | chr14: 101026020 - 101026107 |
Synonyms | MIRN758, hsa-mir-758, MIR758 |
Description | Homo sapiens miR-758 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-758-5p | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 15| GAUGGUUGACCAGAGAGCACAC |36 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | SOLiD | |||||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | UBE2D4 | ||||||||||||||||||||
Synonyms | HBUCE1 | ||||||||||||||||||||
Description | ubiquitin conjugating enzyme E2 D4 (putative) | ||||||||||||||||||||
Transcript | NM_015983 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on UBE2D4 | |||||||||||||||||||||
3'UTR of UBE2D4 (miRNA target sites are highlighted) |
>UBE2D4|NM_015983|3'UTR 1 GTGCCTTGGAGGTTTTACATGAGACACTGTCCAAGAGAAGCTGGCAGAGAGGTCTTCCCTTAAAACTTTGGGCTGTTGGC 81 TGAGCCATTCAAAGAGCATCATCTGTTCTTCAAACAAATGTTGGTCACCCACTCTCTCCAGCTGCAGCATGTTGGTGCCA 161 TTTTCAGCAATTACGGCTTTGACAGTGCCACCTCTTTGATGCCAAATCAGCAACCATTGTTGTTATGATCTGCAGTCTTC 241 CTGGTGACACTGGAATCTCTCTCTCTGCCGCCTCAGTTTGTCTGCTGGTCTCTTGGGGGGCCAGGCCCTGCACGTCTCTC 321 CTACCCGGCCTCAAATGGTGCTGCTGCCCATGATGGTACCACACCAGGGCCTCAGCCTGGCCCCTCACCACATACCCTTT 401 GCCTTTTAGAACTCAGTGCCATCCTGGGTGCCCAGGGCAGAGCAGGCTTTGTTCGCACCTCATCTGCTGCAGAACCACAT 481 CCTGAGGAGTCTCAGCTTATCCTGGAGGGAATTGGGAACAGTGTCACTGGGAAGTGAAGGCCTAGCCCTGTGGCTTCCAC 561 CAGTCTCCTCCTGCAGTGCCACGTGGTGGCATTTCTCGCCTCACACCAAGAAGCAGCAAGTGGAAAATTTCAGGATACAA 641 AGCACATAACACCCCATAAGAGATGATTATGTTTTTAGAAGCAAGAGCAAAATTATGAAACCTCTAGAGATTTGGGTCAT 721 GTTACTCCATTTGATGAAGATTCTCACTACCGCCCGCTCCTCCCATAGGAGCCTACACTAAGTCCAAGTGTGAGCCATTC 801 ACAGACTAGAACACAAGGAGGGAGAGAGACTCTTAAACGTAAATAAAAATGCAATTCACTCACAACTCTAAATGATAATT 881 GACATTTCAGCCTCTTTCTTTTAGGCAAAACAGAAGATACACACTATTAACAGTTATTTGAAGCCTTAAATTACAATAGC 961 CTGTTAGGTGATCGGCTTTCTGCCTTGGCTTTCTGATGCAGCACATTTTAAGATTTGCCTTTAAAGCTTTGAGCCTTGAG 1041 ATTAGGTTAGTTAGGAAGAGGACAACAAAGGGAAGAGATTATTCTAATAAAACTTCCACAGAGGGAAGAAAATTGAGGAG 1121 CTTCAGATCTCTAAAGCCAAATTCAACCTGATCTTTCTAGGTTGGTTATAAAGCTGGTCCACTTCCAGGAAGTGATGTGT 1201 AGGTGAATAGGAACAAAAGGTGAAGAAGCAGTAAAACTGTGACCAAGTGGCCAGATGGGGCTTTTGCCGGCTGATTGAAA 1281 GGAAGTCTACAGACCTAACATAAGCAGTCAGCCAAAGGTGGCTGTGGGAGGTTGATTTCTTCCAGAAACTTCCAAGTTGT 1361 GGCTACAAATTTATTGCCAGATATTTTCCCACTGAGAATACTGAGGTTATTCACATAATCACTTCCTTAACAAAGGAAGA 1441 AGCACTTTTAACTTGGGCTGCATTCCCTTTGTGAGGGTCCACATTTAGGATCCTCCTGCTACCATAAGGCCCCTTTTGGG 1521 GTTCTTTGGGTGTGGCTGCATCTCACCATGTTGAGGATTGCCTTTTTTTTTTTTTTTTTTTTTTTTTTTTAACACAGAGC 1601 CTTGCTCTGTCTCCCAGGCTGGAGTGCAGTGGTGCGATCTTGGCTCACTGCAACCTCTGCCTCCCAGGTTCAAGCAATTC 1681 TCCTGCCTCAGCCTCCCAAGTAGCCGGAATTACAGGCATGTGCCACCATGCTGGGCTAATTTTTGTATTTTTAGTGGAGA 1761 CGGTGTTTCACCATGTTGGCCAGGCTGTTCTTGAACTCCTGGCCTCAAGTGACCCGCCCACATTGGCCTCCCAAAGTGCT 1841 GGGATTACAGGCGTGAGCCCCCGTGCCCAGCAAGGATTGCTGTTTTAATTCTTGTATCTTCGTTGCTTCTTTGGTCTTTG 1921 CTTAAACAAAACAATAAAGCTTAATAGTTGGGGAGAATGCTGTTACCAGTGTCCTCTAGGAAGGCTGTTAGCATATGGCT 2001 CTACTGAGCAGCAGTGCCATCTGGTGCCTGAGATCATGTGCTTCAGGCAGTTGTCACACTGCATCTACAGCCAAGCATCA 2081 CAGAAACACTTCACTCATGTGGTCAGGGAAGGTGGGACTGATTCACATGTTAGAGACAGGTCAGATGGGAAAATTAAGGC 2161 CCAACTTGGTGTTGGGGAATAACCATACTCTGGTCTTTCAAGTGTAGTAGCTGATGATTCCCAAGAAACTGATGAATTTT 2241 CTGAGTCCAGACAAAATTTCCCCAAGCCTGCTCTCTCTGTTGGATATACATAATAGAGAAAGTCAAATCAGCCCTTTGGG 2321 GTTTGTGGTAAAAATTCACTCACCCATTGAAGCCTAAGGTGGCTTTGTACCTTCCAGATCTCTCAGCAAATCCCCTGGGC 2401 AGAAATGTCACCTGCTTGCCATGTCTTTGAGGGGTTCAGGTCAGCCTGGAGAACAGGCTCCTTAGGTCAAAAACCTTGTT 2481 TTAAGAGCCACTGTGGTACAGTCAATGTAACCCACTTGTGCAGAAGCCATGCTTCCAAGGAAGGTCTCAGGTTGACAACT 2561 AGACATCAAATCTGAGAAGCCAACTGTGGAGTAATGTGTTTTTTTCTCTGTGGACAAGAGTGATCAGAAAGGTGCTTGAT 2641 CTTGAACAATTGATCCATGATGAAAAAATGACCATTAGCTCTCCCCCAGAAGCGTCTGTGTTTGCTGAATGGAGCTGAGA 2721 TTTTGATCCGCTATCAGACTCCAGAAAGATCCAGGAGTTCCAAGAACATGGCAAAGAGTCAAAATCTTAGGACAAGGAAT 2801 TAAAATGCCAGAATGCAAATGTCCAACAGGCCTGGTAGCTCACAGCTATCAACACCCTAGAATTCCACACTGCCTCACTG 2881 CAGTTGCTCAAGGATGGGTATGTTTCTGTCTCTGAAATTCGGGAAAAAGCCTTAAGTGCCAGAGAAGGTGCTTCCAAGAC 2961 TGTCTGCAGAATTCCTTTCCTAGGGTCTGTCTCTGGTACCCAAAAGGGCAGAGAAGGAACCCTAAGATTAGCATAGAGCC 3041 ACTCATCTCTCCTCCCCTCCCCACCCCTTCTTCCCCTGCTTCCATTCCCCATGGCTCTCTCCTCTGACTGTGAAACACTT 3121 CCTCTCCAGCAGTGTTGGGAAAGTTCTGGACCTCTACTGGATCTAGCCATAAATGGTGGTCTTCAGAAAAATGGAGATTG 3201 TGGCTGCCAGCACCCACAAGACAGCAGCCTCATGCCATGCAGGCAGCAAGCCATCCTGAACAGCGTTCCTCCCAGAGTCT 3281 GTTTCCTCACCTGCTGTTCACTGGTGAGAGGAAAAGGGACTTGTTCTCCCTTGACCAGTTTTCTAGTTTTCCTGTTCCCA 3361 CCCTGGTCTTTGCCTGATGACAGAGAAACTTTCTAAAAAAAAACAAAAACAAAAGCTATAAAAAATCTGCAAAACACCCT 3441 AAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 51619.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000222402.3 | 3UTR | AAUCAGCAACCAUUGUUGUUAUGAUCUGCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000222402.3 | 3UTR | AAAUCAGCAACCAUUGUUGUUAUGAUCUGCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
62 hsa-miR-758-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT085323 | MORC3 | MORC family CW-type zinc finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT089441 | STAMBP | STAM binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT089456 | TET3 | tet methylcytosine dioxygenase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT111856 | CCND1 | cyclin D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT184933 | ZNF268 | zinc finger protein 268 | ![]() |
![]() |
2 | 2 | ||||||
MIRT215288 | CREBRF | CREB3 regulatory factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT237300 | LPP | LIM domain containing preferred translocation partner in lipoma | ![]() |
![]() |
2 | 2 | ||||||
MIRT238446 | MYO10 | myosin X | ![]() |
![]() |
2 | 4 | ||||||
MIRT273827 | RPL41 | ribosomal protein L41 | ![]() |
![]() |
2 | 2 | ||||||
MIRT282703 | HOOK1 | hook microtubule tethering protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT347970 | ZNF850 | zinc finger protein 850 | ![]() |
![]() |
2 | 2 | ||||||
MIRT371076 | KLF3 | Kruppel like factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464339 | USP6NL | USP6 N-terminal like | ![]() |
![]() |
2 | 2 | ||||||
MIRT470034 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477506 | ELL2 | elongation factor for RNA polymerase II 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482886 | CACNA2D3 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492606 | POLR3E | RNA polymerase III subunit E | ![]() |
![]() |
2 | 2 | ||||||
MIRT502294 | GNG12 | G protein subunit gamma 12 | ![]() |
![]() |
2 | 6 | ||||||
MIRT507600 | DCTN4 | dynactin subunit 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510728 | SON | SON DNA binding protein | ![]() |
![]() |
2 | 6 | ||||||
MIRT514065 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | ![]() |
![]() |
2 | 8 | ||||||
MIRT519718 | ZNF512B | zinc finger protein 512B | ![]() |
![]() |
2 | 4 | ||||||
MIRT520890 | STRN | striatin | ![]() |
![]() |
2 | 2 | ||||||
MIRT521760 | PPIL1 | peptidylprolyl isomerase like 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT526874 | ERCC8 | ERCC excision repair 8, CSA ubiquitin ligase complex subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT530232 | WSB2 | WD repeat and SOCS box containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532003 | ACTR2 | ARP2 actin related protein 2 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT533371 | UBE2D4 | ubiquitin conjugating enzyme E2 D4 (putative) | ![]() |
![]() |
2 | 4 | ||||||
MIRT547106 | PIGW | phosphatidylinositol glycan anchor biosynthesis class W | ![]() |
![]() |
2 | 2 | ||||||
MIRT548189 | FOXA1 | forkhead box A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT552935 | VKORC1L1 | vitamin K epoxide reductase complex subunit 1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560085 | ZNF195 | zinc finger protein 195 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561726 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT562713 | ZNF415 | zinc finger protein 415 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562761 | ZNF846 | zinc finger protein 846 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564159 | ZNF117 | zinc finger protein 117 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565673 | SETD5 | SET domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565718 | SESN3 | sestrin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566026 | RFX1 | regulatory factor X1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569048 | ZNF655 | zinc finger protein 655 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570367 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570410 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT570443 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 2 | ||||||
MIRT571738 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575042 | Tpgs2 | tubulin polyglutamylase complex subunit 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT614330 | ZDHHC22 | zinc finger DHHC-type containing 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617629 | RAB3IP | RAB3A interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT621667 | UBE4B | ubiquitination factor E4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT639906 | SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651436 | XRCC5 | X-ray repair cross complementing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683853 | ZNF208 | zinc finger protein 208 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684841 | TPGS2 | tubulin polyglutamylase complex subunit 2 | ![]() |
![]() |
2 | 5 | ||||||
MIRT689347 | ZNF83 | zinc finger protein 83 | ![]() |
![]() |
2 | 2 | ||||||
MIRT692492 | SPIN4 | spindlin family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695711 | OLA1 | Obg like ATPase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698219 | TMEM248 | transmembrane protein 248 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711560 | FAM20B | FAM20B, glycosaminoglycan xylosylkinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT712867 | TMEM67 | transmembrane protein 67 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722956 | TSPAN1 | tetraspanin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT723622 | SOBP | sine oculis binding protein homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT724176 | ABCF2 | ATP binding cassette subfamily F member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT755363 | LMBR1 | limb development membrane protein 1 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|